Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system
European Journal of Cancer(2023)
摘要
•Liquid NGS finds treatable mutations in over 60% of East Asian NSCLC patients.•Upfront liquid NGS shortens the time to treatment by 8 days in advanced NSCLC.•Liquid NGS detects 42.6% of cases missed by four-gene tissue testing.
更多查看译文
关键词
NGS,Liquid biopsy,Lung cancer,CfDNA
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要